hsa-miR-522-3p

ncRNA information

ncRNA name

hsa-miR-522-3p

Specific or universal ncRNAs

Specific ncRNAs

Class

MicroRNA

Biomarker

None

Biomarker application

Upstream regulatory factors

Not available

Downstream target

E2F2

Cancer information

Cancer name

Ovarian Cancer

Cancer site

qRT-PCR,Western blot,Luciferase assay

Treatment information

Treatment type

Chemotherapy

Drug

Paclitaxel

Impact of wild-type ncRNA on chemotherapy resistance

Down

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

miR-522-3p attenuated the degree of paclitaxel resistance in vitro through the downregulation of E2F2

Tissue resource

ovarian cancer cell lines SKOV3ip1

ovarian cancer cell lines HeyA8

Experiment

None


Institute

University of Chicago

MD Anderson Cancer Center

Country

United States

United States

Continent

North Amercian

North Amercian